{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:11:00Z","timestamp":1751602260280,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Substance use treatment (SUT) and harm reduction are often perceived as having distinct goals despite people who use drugs routinely having needs that encompass both services. The co-occurring SUT and harm reduction needs of people who use drugs warrant collaboration between service providers. However, little work has explored such collaborations, or lack thereof. This research explores how SUT providers responded to expanded harm reduction programming from the perspectives of syringe services program (SSP) operators in Michigan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted in-depth, semi-structured interviews with a geographically diverse sample of SSP operators (<jats:italic>n<\/jats:italic>\u2009=\u200919) in Michigan during October and November 2021. The interview guide broadly explored the contributing factors to SSP implementation, including SSP relationships with SUT providers. Analyses of transcribed interviews were conducted using an iterative, thematic constant comparison process informed by grounded theory.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Participants described a range of responses to SSP implementation from SUT providers. Many SSP operators identified significant barriers to effective collaboration with SUT providers due to lack of awareness about harm reduction approaches and stigmatization of drug use. For example, SUT providers were often reluctant to accept free harm reduction supplies (e.g., sterile syringes, naloxone) to offer their clients. Participants also reported difficulties connecting their clients to evidence-based SUT providers. Incremental relationship building and education about the role of harm reduction in recovery were required for effective collaboration between SUT providers and SSPs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Tensions between SUT and harm reduction providers may create challenges that impede recovery among people who use drugs. Ensuring SUT and harm reduction providers understand the unique and complementary roles of each approach is necessary to advance the health of people who use drugs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12954-025-01172-5","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:31:12Z","timestamp":1740803472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives of syringe services program operators in Michigan on their relationship with substance use treatment: a qualitative study"],"prefix":"10.1186","volume":"22","author":[{"given":"Molly C.","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Gattine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zekiye","family":"Lukco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Hool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Alonso","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Tomko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Whaley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"1172_CR1","unstructured":"CDC\/National Center for Health Statistics. Drug overdose deaths in the US top 100,000 annually. 2021. https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm."},{"key":"1172_CR2","first-page":"423","volume":"67","author":"H Hagan","year":"2000","unstructured":"Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt. Sinai J Med N Y. 2000;67:423\u20138.","journal-title":"Sinai J Med N Y"},{"key":"1172_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-022-03861-9","author":"SJ Harris","year":"2022","unstructured":"Harris SJ. An early implementation analysis of syringe services programs in Kentucky: barriers and facilitators identified by program operators and local officials. AIDS Behav. 2022. https:\/\/doi.org\/10.1007\/s10461-022-03861-9.","journal-title":"AIDS Behav"},{"key":"1172_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2105\/AJPH.2019.305515","volume":"110","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. Expansion of syringe service programs in the United States, 2015\u20132018. Am J Public Health. 2020;110:517\u20139. https:\/\/doi.org\/10.2105\/AJPH.2019.305515.","journal-title":"Am J Public Health"},{"key":"1172_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1026532832250","volume":"33","author":"CE Gent","year":"2000","unstructured":"Gent CE. Needle exchange policy adoption in American cities: why not? Policy Sci. 2000;33:125\u201353. https:\/\/doi.org\/10.1023\/A:1026532832250.","journal-title":"Policy Sci"},{"key":"1172_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235\u201348. https:\/\/doi.org\/10.1093\/ije\/dyt243.","journal-title":"Int J Epidemiol"},{"key":"1172_CR7","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1007\/s10461-019-02615-4","volume":"23","author":"M Adams","year":"2019","unstructured":"Adams M, An Q, Broz D, Burnett J, Wejnert C, Paz-Bailey G, For the NHBS Study Group. Distributive syringe sharing and use of Syringe Services Programs (SSPs) among persons who inject drugs. AIDS Behav. 2019;23:3306\u201314. https:\/\/doi.org\/10.1007\/s10461-019-02615-4.","journal-title":"AIDS Behav"},{"key":"1172_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","volume":"91","author":"H Hagan","year":"2001","unstructured":"Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42\u20136.","journal-title":"Am J Public Health"},{"key":"1172_CR9","unstructured":"Lauritsen KJ. Do psychological characteristics of addiction treatment professionals predict acceptance of harm reduction interventions? Bowling Green State University. 2017. https:\/\/etd.ohiolink.edu\/acprod\/odb_etd\/etd\/r\/1501\/10?clear=10%26;p10_accession_num=bgsu1497572679919639. Accessed 1 Apr 2024."},{"key":"1172_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1037\/0893-164X.17.3.203","volume":"17","author":"H Rosenberg","year":"2003","unstructured":"Rosenberg H, Phillips KT. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychol Addict Behav. 2003;17:203\u201310. https:\/\/doi.org\/10.1037\/0893-164X.17.3.203.","journal-title":"Psychol Addict Behav"},{"key":"1172_CR11","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1007\/s11606-021-06904-4","volume":"36","author":"JL Taylor","year":"2021","unstructured":"Taylor JL, Johnson S, Cruz R, Gray JR, Schiff D, Bagley SM. Integrating harm reduction into outpatient opioid use disorder treatment settings. J Gen Intern Med. 2021;36:3810\u20139. https:\/\/doi.org\/10.1007\/s11606-021-06904-4.","journal-title":"J Gen Intern Med"},{"key":"1172_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1891\/0047-2220.37.1.38","volume":"37","author":"JE Havranek","year":"2006","unstructured":"Havranek JE, Stewart JR. Rehabilitation counselors\u2019 attitudes toward Harm reduction measures. J Appl Rehabil Couns. 2006;37:38\u201344. https:\/\/doi.org\/10.1891\/0047-2220.37.1.38.","journal-title":"J Appl Rehabil Couns"},{"key":"1172_CR13","doi-asserted-by":"publisher","first-page":"111040","DOI":"10.1016\/j.drugalcdep.2023.111040","volume":"254","author":"R Heimer","year":"2024","unstructured":"Heimer R, Black AC, Lin H, Grau LE, Fiellin DA, Howell BA, Hawk K, D\u2019Onofrio G, Becker WC. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016\u201317. Drug Alcohol Depend. 2024;254:111040. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.111040.","journal-title":"Drug Alcohol Depend"},{"key":"1172_CR14","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"SE Wakeman","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, Chaisson CE, McPheeters JT, Crown WH, Azocar F, Sanghavi DM. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw. Open. 2020;3:e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622.","journal-title":"Open"},{"key":"1172_CR15","unstructured":"Prescription drug abuse policy system: syringe services programs laws. n.d. https:\/\/www.pdaps.org\/datasets\/syringe-services-programs-laws"},{"key":"1172_CR16","unstructured":"Opioid Resources. Michigan.Gov. n.d. https:\/\/www.michigan.gov\/opioids."},{"key":"1172_CR17","unstructured":"CDC\/National Center for Health Statistics. Drug overdose mortality by state. 2022. https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm."},{"key":"1172_CR18","unstructured":"AIDSVu - Local Data: Michigan. AIDSVu.Org. n.d. https:\/\/aidsvu.org\/local-data\/united-states\/midwest\/michigan\/."},{"key":"1172_CR19","unstructured":"Syringe Access in Your State. Natl. Harm Reduct. Coalit. n.d. https:\/\/harmreduction.org\/issues\/syringe-access\/landscape-report\/state-by-state\/. Accessed 28 May 2024."},{"key":"1172_CR20","unstructured":"Bohnert A, Erb-Downward J, Thomas I. Opioid addiction: meeting the need for treatment in Michigan. Poverty Solutions - University of Michigan. 2019. https:\/\/poverty.umich.edu\/files\/2019\/05\/PovertySolutions-OpioidTreatment-PolicyBrief-r4.pdf."},{"key":"1172_CR21","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1693969\/v1","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Allen ST, Schneider KE, Solomon K, Shah H, Morris M, Harris SJ, Sherman SG, Saloner B. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service-needs of a community-based sample of people who use drugs. In Review. 2022. https:\/\/doi.org\/10.21203\/rs.3.rs-1693969\/v1.","journal-title":"Rev"},{"key":"1172_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, Grieb SM, O\u2019Rourke A, Yoder R, Planchet E, White RH, Sherman SG. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16:33. https:\/\/doi.org\/10.1186\/s12954-019-0305-7.","journal-title":"Harm Reduct J"},{"key":"1172_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.drugpo.2015.04.008","volume":"26","author":"ST Allen","year":"2015","unstructured":"Allen ST, Ruiz MS, O\u2019Rourke A. The evidence does not speak for itself: the role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities. Int J Drug Policy. 2015;26:688\u201395. https:\/\/doi.org\/10.1016\/j.drugpo.2015.04.008.","journal-title":"Int J Drug Policy"},{"key":"1172_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/07853890.2022.2028001","volume":"54","author":"ST Allen","year":"2022","unstructured":"Allen ST, Grieb SM, Glick JL, White RH, Puryear T, Smith KC, Weir BW, Sherman SG. Applications of research evidence during processes to acquire approvals for syringe services program implementation in rural counties in Kentucky. Ann Med. 2022;54:404\u201312. https:\/\/doi.org\/10.1080\/07853890.2022.2028001.","journal-title":"Ann Med"},{"key":"1172_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12954-022-00631-7","volume":"19","author":"JL Glick","year":"2022","unstructured":"Glick JL, Grieb SM, Harris SJ, Weir BW, Smith KC, Puryear T, Hamilton White R, Allen ST. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky. Harm Reduct J. 2022;19:47. https:\/\/doi.org\/10.1186\/s12954-022-00631-7.","journal-title":"Harm Reduct J"},{"key":"1172_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1023\/A:1020909529486","volume":"36","author":"H Boeije","year":"2002","unstructured":"Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36:391\u2013409. https:\/\/doi.org\/10.1023\/A:1020909529486.","journal-title":"Qual Quant"},{"key":"1172_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1077800416657105","volume":"23","author":"K Charmaz","year":"2017","unstructured":"Charmaz K. The power of constructivist grounded theory for critical inquiry. Qual Inq. 2017;23:34\u201345. https:\/\/doi.org\/10.1177\/1077800416657105.","journal-title":"Qual Inq"},{"key":"1172_CR28","doi-asserted-by":"publisher","unstructured":"Charmaz K, Belgrave LL, Grounded Theory. In: The Blackwell Encyclopedia of Sociology. John Wiley & Sons, Ltd; 2015. https:\/\/doi.org\/10.1002\/9781405165518.wbeosg070.pub2.","DOI":"10.1002\/9781405165518.wbeosg070.pub2"},{"key":"1172_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/14780887.2013.853855","volume":"11","author":"D Sousa","year":"2014","unstructured":"Sousa D. Validation in qualitative research: general aspects and specificities of the descriptive phenomenological method. Qual Res Psychol. 2014;11:211\u201327. https:\/\/doi.org\/10.1080\/14780887.2013.853855.","journal-title":"Qual Res Psychol"},{"key":"1172_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/0890334419830990","volume":"35","author":"JE Dodgson","year":"2019","unstructured":"Dodgson JE. Reflexivity in qualitative research. J Hum Lact Off J Int Lact Consult Assoc. 2019;35:220\u20132. https:\/\/doi.org\/10.1177\/0890334419830990.","journal-title":"Off J Int Lact Consult Assoc"},{"key":"1172_CR31","first-page":"41","volume":"7","author":"C McKim","year":"2023","unstructured":"McKim C. Meaningful member-checking: a structured approach to member-checking. Am J Qual Res. 2023;7:41\u201352.","journal-title":"Am J Qual Res"},{"key":"1172_CR32","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/09687637.2021.1936457","volume":"29","author":"SH Sulzer","year":"2022","unstructured":"Sulzer SH, Prevedel S, Barrett T, Voss MW, Manning C, Madden EF. Professional education to reduce provider stigma toward harm reduction and pharmacotherapy. Drugs Educ Prev Policy. 2022;29:576\u201386. https:\/\/doi.org\/10.1080\/09687637.2021.1936457.","journal-title":"Drugs Educ Prev Policy"},{"key":"1172_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1090198114529131","volume":"41","author":"ND Crawford","year":"2014","unstructured":"Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM. Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users. Health Educ. Behav off Publ Soc Public Health Educ. 2014;41:397\u2013405. https:\/\/doi.org\/10.1177\/1090198114529131.","journal-title":"Behav off Publ Soc Public Health Educ"},{"key":"1172_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.addbeh.2016.05.013","volume":"61","author":"AK Gatewood","year":"2016","unstructured":"Gatewood AK, Van Wert MJ, Andrada AP, Surkan PJ. Academic physicians\u2019 and medical students\u2019 perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addict Behav. 2016;61:40\u20136. https:\/\/doi.org\/10.1016\/j.addbeh.2016.05.013.","journal-title":"Addict Behav"},{"key":"1172_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.drugpo.2012.05.001","volume":"23","author":"PJ Davidson","year":"2012","unstructured":"Davidson PJ, Lozada R, Rosen PC, Macias A, Gallardo M, Pollini RA. Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico. Int J Drug Policy. 2012;23:286\u201394. https:\/\/doi.org\/10.1016\/j.drugpo.2012.05.001.","journal-title":"Int J Drug Policy"},{"key":"1172_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11673-016-9720-6","volume":"13","author":"E Drucker","year":"2016","unstructured":"Drucker E, Anderson K, Haemmig R, Heimer R, Small D, Walley A, Wood E, van Beek I. Treating addictions: harm reduction in clinical care and prevention. J Bioethical Inq. 2016;13:239\u201349. https:\/\/doi.org\/10.1007\/s11673-016-9720-6.","journal-title":"J Bioethical Inq"},{"key":"1172_CR37","unstructured":"Resource Center. Natl. Harm Reduct. Coalit. n.d. https:\/\/harmreduction.org\/resource-center\/. Accessed 4 Mar 2024."},{"key":"1172_CR38","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2105\/AJPH.2012.301178","volume":"103","author":"ND Crawford","year":"2013","unstructured":"Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City. Am J Public Health. 2013;103:1579\u201382. https:\/\/doi.org\/10.2105\/AJPH.2012.301178.","journal-title":"Am J Public Health"},{"key":"1172_CR39","doi-asserted-by":"crossref","unstructured":"Johnson BD, Golub A, Deren S, Jarlais DC, Fuller C, Vlahov D. The nonimpact of the expanded syringe access program upon heroin use, injection behaviours, and crime indicators in New York City and State. Justice Res. Stat. Assoc. 2006;8. https:\/\/journals.sagepub.com\/doi\/10.3818\/JRP.8.1.2006.27?icid=int.sj-abstract.similar-articles.3. Accessed 6 Mar 2024.","DOI":"10.3818\/JRP.8.1.2006.27"},{"key":"1172_CR40","volume-title":"Results from the 2019 National Survey on Drug Use and Health, Center for Behavioral Health Statistics and Quality","author":"Substance Abuse and Mental Health Services Administration, Key Substance Use and Mental Health Indicators in the United States","year":"2019","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019."},{"key":"1172_CR41","unstructured":"Substance Abuse and Mental Health Services Administration. Harm reduction framework, center for substance abuse prevention, substance abuse and mental health services administration. 2023. https:\/\/www.samhsa.gov\/sites\/default\/files\/harm-reduction-framework.pdf."},{"key":"1172_CR42","unstructured":"Meines C. New Michigan laws expand access to drug treatment options. 2024. https:\/\/www.uppermichiganssource.com\/2024\/03\/19\/new-michigan-laws-expand-access-drug-treatment-options\/. Accessed 4 Apr 2024."},{"key":"1172_CR43","unstructured":"Allen S, Grieb SM, Harris SJ, Tomko C, Urquhart G, Alonso F. Lessons learned during the launch of syringe services programs in Michigan. Johns Hopkins University. 2023. https:\/\/opioidprinciples.jhsph.edu\/wp-content\/uploads\/2023\/02\/JHU-027-Syringe-Services-Report-FINAL-v1.9.23-3-23.pdf. Accessed 12 Sep 2024."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01172-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:15:24Z","timestamp":1751562924000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1172"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01172-5","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}